NASDAQ ยท Price History

Seaport Therapeutics, Inc. Common Stock (SPTX) Price History & Returns

$20.61 NASDAQ: SPTX Market Cap $1.10B

How Seaport Therapeutics, Inc. Common Stock (SPTX) has performed, year by year and over each trailing period. Price history only โ€” total return to a shareholder would also include dividends.

The share price of $20.61 sits 43% of the way up a 52-week range of $14.85 to $28.38; 27.4% below the 52-week high; below its 50-day moving average of $21.52; above its 200-day average of $20.11; a beta of 1.13 means it has historically moved more than the market.

Total return

Price change over each trailing period, not annualised.

PeriodReturn
3 months-2.3%
6 months+0.0%
1 year+0.0%
3 years+0.0%
5 years+0.0%
10 years+0.0%

Monthly closing prices

The last 6 months, newest first. 3 of 5 months closed higher than the month before. Each figure is the last close in that month.

MonthCloseChange
October 2026$20.61+2.2%
September 2026$20.17-14.8%
August 2026$23.68+15.7%
July 2026$20.46-5.8%
June 2026$21.72+19.4%
May 2026$18.19โ€”

Seaport Therapeutics, Inc. Common Stock (SPTX) price history โ€” frequently asked questions

How has Seaport Therapeutics, Inc. Common Stock performed over the last year?

Seaport Therapeutics, Inc. Common Stock (SPTX) has risen 0.0% over the last twelve months, measured on price alone.

What is Seaport Therapeutics, Inc. Common Stock's five-year return?

Over five years the SPTX share price has gained 0.0%, excluding dividends.

What is Seaport Therapeutics, Inc. Common Stock's 52-week range?

Over the last year Seaport Therapeutics, Inc. Common Stock (SPTX) has traded between $14.85 and $28.38.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.